Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride, a drug that prevents testosterone conversion, can effectively reduce blood loss in prostate surgery, especially for patients with a prostatic volume over 30 cc, and decrease post-surgery complications.

The new compound may be a safer alternative to finasteride for prostate protection.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

The method is quick and effective for testing steroid 5 alpha-reductase inhibitors.

Ritlecitinib is generally safe for long-term use, with mostly mild side effects.

A new compound, 3a, effectively fights prostate cancer better than finasteride.

Trazodone and chlorpromazine may help treat sexual dysfunction caused by finasteride and SSRIs.

Plant-based compounds may offer safer prostate cancer treatment with fewer side effects.

Ritlecitinib is being tested for effectiveness and safety in treating severe alopecia areata.

Dutasteride is slightly better than finasteride for treating BPH but has fewer sexual side effects.

Doxazosin and finasteride negatively affect sexual function in men with BPH.

Trazodone and Chlorpromazine might help treat sexual dysfunction from finasteride and SSRIs.

Dutasteride is more effective for male pattern baldness than finasteride, and black cohosh extract BNO 1055 is as effective as conjugated estrogens in treating postmenopausal symptoms, with added benefits in reducing sweating and mental symptoms.

Finasteride significantly reduced tics and obsessive-compulsive symptoms in Tourette syndrome patients.

Oral tofacitinib effectively treats alopecia areata long-term with manageable side effects.

Finasteride reduces PSA levels, terazosin doesn't affect them, and tracking prostate cancer in patients taking finasteride could be difficult.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

A new drug, dutasteride, is at least as effective as the older drug, finasteride, for treating enlarged prostate and may have additional uses.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Tofacitinib effectively regrows hair in alopecia areata patients, especially in younger individuals, with manageable side effects.

Tofacitinib is effective and has minor, reversible side effects for treating severe hair loss in Iran.

Topical finasteride with EGCG or TA improves drug release and dermal uptake, potentially treating hair loss effectively.

Prescriptions for 5-alpha reductase inhibitors dropped significantly after the FDA's safety warning, especially for men with benign prostatic hyperplasia.

Trazodone might help reverse post finasteride syndrome.

Finasteride safely reduces excessive hair growth in women.

Talazoparib is more effective than standard chemotherapy for advanced breast cancer with BRCA mutations.